Mobile

A phase IV, 6-week, randomised, double-blind, multicentre, parallel group, comparative study to evaluate the efficacy of rosuvastatin 5 mg and atorvastatin 10 mg in UK Asian subjects with primary hype...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003286-14

A phase IV, 6-week, randomised, double-blind, multicentre, parallel group, comparative study to evaluate the efficacy of rosuvastatin 5 mg and atorvastatin 10 mg in UK Asian subjects with primary hypercholesterolaemia

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this UK study is to compare the efficacy of rosuvastatin 5 mg with atorvastatin 10 mg in reducing LDL-C in Asian subjects with hypercholesterolaemia after 6 weeks of treatment.

Critère d'inclusion

  • Hypercholesterolaemia

Liens